Patient Blood Management
by Irwin Gross, MD
Presentation date: May 22, 2012
Expiration date: May 22, 2015
Approximately 1.0 hours
Irwin Gross, M.D. is Medical Director of Transfusion Services at Eastern Maine Medical Center in Bangor, Maine. He is also Medical Director of Eastern Maine Medical Center's Blood Management and Conservation Program. He is board certified in Clinical and Anatomic Pathology by the American Board of Pathology, and serves the Board of the Society for the Advancement of Blood Management. From 1985 through 1998, Dr. Gross practiced general anatomic and clinical pathology at Eastern Maine Medical Center and served as medical director of several small rural hospital laboratories in the region. In 1999, Dr. Gross was appointed Medical Director of Affiliated Laboratories. While he was Medical Director, his particular areas of interest were hematopathology, coagulation, and transfusion medicine. In the fall of 2006, Dr. Gross began the Eastern Maine Medical Center Blood Management and Conservation Program. In addition to ongoing efforts to reduce allogeneic transfusions, Eastern Maine Medical Center is developing a program to help providers actively manage anemia before, during, and after hospitalization. Since the beginning of their patient blood management program, EMMC has reduced allogeneic red cell transfusions by over 50%.
Disclosure of Financial Relationships:
As it pertains to CME, Irwin Gross, MD - Medical Advisory Board - Strategic Healthcare Group.
Upon completion of this CME activity, the participant should be able to:
1. Describe the key elements of a comprehensive patient blood management program.
2. List three adverse consequences of rod cell transfusion.
3. Define 'Storage Lesion'.
4. Name two options for perioperative autologous cell collection and administration.